| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.1 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |